Savara to present at the jefferies london healthcare conference

Austin, texas--(business wire)--savara inc. (nasdaq: svra), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will present at the jefferies london healthcare conference being held november 16-19, 2021. a pre-recorded, on-demand webcast of savara's presentation will be available on the conference website beginning thursday, november 18 at 3:00 am et through friday, november 19 at 12:00 pm et. additionally, a replay of the pr
SVRA Ratings Summary
SVRA Quant Ranking